We found that PGM5-AS1 expression was significantly lower in NSCLC tissues compared with NATs (Fig. 1B) and that PGM5-AS1 was down-regulated in 43 of 50 NSCLC cohorts (Fig. 1C). Here, PGM5 is linked to non-small cell lung carcinoma.